amitriptyline has been researched along with Cockayne-Touraine Disease in 2 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferreira, S | 1 |
| Azevedo, A | 1 |
| Velho, GC | 1 |
| Sanches, M | 1 |
| Selores, M | 1 |
| Mangold, AR | 1 |
| Cole, CM | 1 |
| DiCaudo, DJ | 1 |
| Pittelkow, MR | 1 |
| Sekulic, A | 1 |
2 other studies available for amitriptyline and Cockayne-Touraine Disease
| Article | Year |
|---|---|
Epidermolysis Bullosa Pruriginosa successfully treated with concomitant topical and systemic agents.
Topics: Administration, Topical; Amitriptyline; Analgesics; Drug Therapy, Combination; Epidermolysis Bullosa | 2020 |
Treatment of epidermolysis bullosa pruriginosa using systemic and topical agents.
Topics: Administration, Oral; Administration, Topical; Amitriptyline; Drug Therapy, Combination; Epidermolys | 2014 |